Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy
ConclusionsOverall dispense of AOM from 2002 reached a peak in 2007 and thereafter declined despite increases in therapeutic options and improved subsidised access. The recent decline in overall AOM dispensing seems to be explained largely by negative publicity rather than specific changes in guidelines and policy. Copyright © 2014 John Wiley & Sons, Ltd.
Source: Pharmacoepidemiology and Drug Safety - Category: Drugs & Pharmacology Authors: Geeske Peeters, Susan E. Tett, Emma L. Duncan, Gita D. Mishra, Annette J. Dobson Tags: Original Report Source Type: research
More News: Actonel | Drugs & Pharmacology | Hormone Replacement Therapy | Hormones | Orthopaedics | Osteoporosis | Reclast | Risedronate | Study | Women | Zometa